KY1220,98.0%
产品编号:Bellancom-102028| CAS NO:292168-79-7| 分子式:C14H10N4O3S| 分子量:314.32
本网站销售的所有产品仅用于工业应用或者科学研究等非医疗目的,不可用于人类或动物的临床诊断或者治疗,非药用,非食用,
KY1220
| 产品介绍 | KY1220作用于 Wnt/β-catenin 靶点,使β-catenin 和 Ras不稳定。在HEK293报告细胞中的IC50 值为2.1 μM。 | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 生物活性 | KY1220 is a compound that destabilizes both β-catenin and Ras, via targeting the Wnt/β-catenin pathway; with an IC50 of 2.1 μM in HEK293 reporter cells.  | ||||||||||||||||
| 体外研究 |                                         
                                        
                                             KY1220 shows an IC50 of 2.1 μM in HEK293 reporter cells. KY1220 dose dependently decreases Wnt3a-CM-induced TOPflash reporter activation and mRNA expression of Wnt target genes CCND1 and MYC in HEK293 cells. In HEK293 cells, both β-catenin and panRas protein levels are similarly reduced in a dose-dependent manner after treatment with KY1220, whereas the mRNA levels of CTNNB1 (which encodes β-catenin), NRAS, KRAS and HRAS remain unchanged. K-Ras, which has a critical role in progression of CRCs, is also destabilized by KY1220 via polyubiquitin-dependent proteasomal degradation. KY1220 accelerates the degradation rates of both β-catenin and Ras in SW480 cell lines. Ras destabilization by KY1220 consequently inhibits the activities of both ERK and Akt, which are downstream effectors of Ras in SW480 cells harboring a KRAS mutation. The proliferation and transformation of the HCT15, SW480, D-WT and D-MT CRC cells are efficiently inhibited after treatment with KY1220. 西域 has not independently confirmed the accuracy of these methods. They are for reference only.  | ||||||||||||||||
| 体内研究 | |||||||||||||||||
| 体内研究 | |||||||||||||||||
| 性状 | Solid | ||||||||||||||||
| 溶解性数据 | 
                                        
                                             In Vitro:  
                                            DMSO : 50 mg/mL (159.07 mM; Need ultrasonic) 配制储备液 
                                                
 
 
                                                    *
                                                     
                                            
                                        
                                        
                                    请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。  | ||||||||||||||||
| 运输条件 | Room temperature in continental US; may vary elsewhere.  | ||||||||||||||||
| 储存方式 | 
                                
  | ||||||||||||||||
| 参考文献 | 
                            
                                    
                                                          
                                                          
                                                          
                                                          
                                                          
                                                          
                                                          
                                                          
                                                          
                                                          
                                                          
                                                          
                                                          
                                                          
                                                          
                                                          
                                                        
 
 
 
 
浙公网安备 33010802013016号